These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 17342338)
1. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study. Cai T; Piazzini M; Nesi G; Taddei I; Sardi I; Detti B; Mondaini N; Dal Canto M; Bartoletti R Oncol Rep; 2007 Apr; 17(4):925-30. PubMed ID: 17342338 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma. Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911 [TBL] [Abstract][Full Text] [Related]
3. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565 [TBL] [Abstract][Full Text] [Related]
4. Behavior of urothelial carcinoma with respect to anatomical location. Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794 [TBL] [Abstract][Full Text] [Related]
5. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744 [TBL] [Abstract][Full Text] [Related]
6. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Lascombe I; Clairotte A; Fauconnet S; Bernardini S; Wallerand H; Kantelip B; Bittard H Clin Cancer Res; 2006 May; 12(9):2780-7. PubMed ID: 16675571 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB; Zeng FH; Sun ZQ Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038 [TBL] [Abstract][Full Text] [Related]
8. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132 [TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306 [TBL] [Abstract][Full Text] [Related]
10. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Popov Z; Gil-Diez de Medina S; Lefrere-Belda MA; Hoznek A; Bastuji-Garin S; Abbou CC; Thiery JP; Radvanyi F; Chopin DK Br J Cancer; 2000 Jul; 83(2):209-14. PubMed ID: 10901372 [TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence for predicting recurrence-free probability of non-invasive high-grade urothelial bladder cell carcinoma. Cai T; Conti G; Nesi G; Lorenzini M; Mondaini N; Bartoletti R Oncol Rep; 2007 Oct; 18(4):959-64. PubMed ID: 17786360 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder. Mahnken A; Kausch I; Feller AC; Krüger S Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma. Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058 [TBL] [Abstract][Full Text] [Related]
16. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805 [TBL] [Abstract][Full Text] [Related]
18. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357 [TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related]
20. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Li M; Song T; Yin ZF; Na YQ Chin Med J (Engl); 2007 Mar; 120(6):469-73. PubMed ID: 17439739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]